May. 16, 2022
NRx Pharmaceuticals Provides Business Update and Reports First Quarter 2022 Financial Results
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP, NRx Pharmaceuticals), a clinical-stage biopharmaceutical company, today announced its financial results for the quarter ended March 31, 2022 and provided a business and clinical update.